Andrew Lac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew Lac has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Joseph W. LaBrie
Department of Psychology, Loyola Marymount University
34 shared publications - Shannon R. Kenney
Behavioral Medicine Department, Butler Hospital, Providence, RI 02906, United States of America; Warren Alpert Medical School of Brown University, Providence, RI 02912, United States of America
19 shared publications William D. Crano
Claremont Graduate University
19 shared publicationsJustin F. Hummer
Department of Psychology, University of Southern California
15 shared publicationsEusebio M. Alvaro
A 1School of Behavioral and Organizational Science, Claremont Graduate University , Claremont, California, USA
13 shared publicationsDale E. Berger
8 shared publications
Latest Publications
- 26 May 2026
- Published by Taylor & Francis in Journal of Personality Assessment
- Vol. 108 (6) , 1-11
Examining Competing Factor Analysis Models of the PCL-5 Applied to the COVID-19 Pandemic
This investigation scrutinized various competing factor structures and psychometric properties for the COVID-19 version of the Posttraumatic Stress Disorder Checklist for DSM-5 (COVID-19 PCL-5) to understand stress reactions to the pandemic. Participants (N = 985) completed this measure with instructions modified to exclusively refer to the COVID-19 pandemic as the stressful index event. Descriptive data showed that 76% of participants experienced at least one COVID-19 traumatic stress symptom. Confirmatory factor analysis evaluated various competing factor structures of the COVID-19 PCL-5: (a) one-factor model, (b) DSM-5 model, (c) dysphoria model, (d) dysphoric arousal model, (e) externalizing behaviors model, (f) anhedonia model, and (g) hybrid model. The factor structure exhibiting the strongest fit indexes was the hybrid model comprising seven factors: reexperiencing, avoidance, negative affect, anhedonia, externalizing behaviors, anxious arousal, and dysphoric arousal. In multiple regression analyses, six of the seven subscales from the COVID-19 PCL-5 hybrid factor structure variously predicted outcomes of depression, anxiety, stress, and coronavirus anxiety. These findings offer insights to researchers and mental health professionals for assessing, conceptualizing, and understanding the multifaceted traumatic stress symptoms attributed to the COVID-19 pandemic.
- 26 May 2026
- Published by Taylor & Francis in Journal of Personality Assessment
- Vol. 108 (6) , 1-11
Examining Competing Factor Analysis Models of the PCL-5 Applied to the COVID-19 Pandemic
This investigation scrutinized various competing factor structures and psychometric properties for the COVID-19 version of the Posttraumatic Stress Disorder Checklist for DSM-5 (COVID-19 PCL-5) to understand stress reactions to the pandemic. Participants (N = 985) completed this measure with instructions modified to exclusively refer to the COVID-19 pandemic as the stressful index event. Descriptive data showed that 76% of participants experienced at least one COVID-19 traumatic stress symptom. Confirmatory factor analysis evaluated various competing factor structures of the COVID-19 PCL-5: (a) one-factor model, (b) DSM-5 model, (c) dysphoria model, (d) dysphoric arousal model, (e) externalizing behaviors model, (f) anhedonia model, and (g) hybrid model. The factor structure exhibiting the strongest fit indexes was the hybrid model comprising seven factors: reexperiencing, avoidance, negative affect, anhedonia, externalizing behaviors, anxious arousal, and dysphoric arousal. In multiple regression analyses, six of the seven subscales from the COVID-19 PCL-5 hybrid factor structure variously predicted outcomes of depression, anxiety, stress, and coronavirus anxiety. These findings offer insights to researchers and mental health professionals for assessing, conceptualizing, and understanding the multifaceted traumatic stress symptoms attributed to the COVID-19 pandemic.
- 26 December 2025
- Published by SAGE Publications in Assessment
Development and Validation of the Motives for Using Substances for Trauma Coping (MUST-Cope) Questionnaire: A Novel Multidimensional Scale to Assess Trauma-Specific Substance Use Coping Motives
The present study sought to develop and validate a novel multidimensional assessment of substance use (SU) coping motives to manage trauma symptoms. In Study 1 ( N = 326 trauma-exposed adults recruited from several online platforms), a set of questionnaire items was created and administered, and exploratory factor analysis was performed. A correlated four-factor structure represented by cognitive-affective motives, physiological motives, sleep motives, and social motives emerged. In Study 2 ( N = 261 trauma-exposed adults recruited from ResearchMatch), confirmatory factor analysis cross-validated the correlated four-factor structure and additionally tested a five-factor higher-order structure. In tests of convergent, discriminant, and criterion validities, the subscales demonstrated differential correlations with previously validated measures of SU motives and positively correlated with higher PTSD symptom severity, functional impairment, and alcohol and drug use severity. The final 31-item Motives for Using Substances for Trauma Coping (MUST-Cope) Questionnaire offers a novel multifactorial measurement instrument to help researchers and clinicians assess and identify functional coping motives for SU that can be targeted in psychosocial treatment.
- 26 December 2025
- Published by SAGE Publications in Assessment
Development and Validation of the Motives for Using Substances for Trauma Coping (MUST-Cope) Questionnaire: A Novel Multidimensional Scale to Assess Trauma-Specific Substance Use Coping Motives
The present study sought to develop and validate a novel multidimensional assessment of substance use (SU) coping motives to manage trauma symptoms. In Study 1 ( N = 326 trauma-exposed adults recruited from several online platforms), a set of questionnaire items was created and administered, and exploratory factor analysis was performed. A correlated four-factor structure represented by cognitive-affective motives, physiological motives, sleep motives, and social motives emerged. In Study 2 ( N = 261 trauma-exposed adults recruited from ResearchMatch), confirmatory factor analysis cross-validated the correlated four-factor structure and additionally tested a five-factor higher-order structure. In tests of convergent, discriminant, and criterion validities, the subscales demonstrated differential correlations with previously validated measures of SU motives and positively correlated with higher PTSD symptom severity, functional impairment, and alcohol and drug use severity. The final 31-item Motives for Using Substances for Trauma Coping (MUST-Cope) Questionnaire offers a novel multifactorial measurement instrument to help researchers and clinicians assess and identify functional coping motives for SU that can be targeted in psychosocial treatment.
- 8 October 2025
- Published by SAGE Publications in Journal of Drug Issues
COVID-19 Fears Trigger Reasons to Drink: Experimental Priming of Pandemic Phobias Causes State Anxiety and State Alcohol Motivations
COVID-19 fears and anxieties have been identified as risks for alcohol tendencies in previous correlational investigations, but the literature has largely neglected scrutinizing these connections using randomized experiments. In this cue-reactivity experiment, questionnaire priming methodology was applied to trigger anxiety and consequently activate drinking motives in adult participants ( N = 423). Participants were randomly assigned to the COVID-19 fear priming group or the control group. In the priming group, fear was induced by exposing participants to threatening item stimuli concerning COVID-19 phobias. MANCOVA and ANCOVAs controlling for drinker status were conducted. The COVID-19 fear priming group compared to the control group endorsed significantly higher scores on state assessments of anxiety and coping, conformity, and social drinking motives, but no difference was exhibited on enhancement drinking motives. Furthermore, structural equation modeling showed that state anxiety mediated the causal effects of the COVID-19 fear priming manipulation on each of the four state drinking motives, as supported by tests of indirect effects. After controlling for state anxiety, the fear priming manipulation directly predicted state social drinking motives, but not coping, enhancement, and conformity drinking motives in this model. Additionally, tests of moderated mediation with drinker status as the moderator of the mediational processes were evaluated. The findings indicate that COVID-19 fears in triggering anxiety reactions are subsequently managed through drinking motives in the effort to alleviate the anxiety.
- 8 October 2025
- Published by SAGE Publications in Journal of Drug Issues
COVID-19 Fears Trigger Reasons to Drink: Experimental Priming of Pandemic Phobias Causes State Anxiety and State Alcohol Motivations
COVID-19 fears and anxieties have been identified as risks for alcohol tendencies in previous correlational investigations, but the literature has largely neglected scrutinizing these connections using randomized experiments. In this cue-reactivity experiment, questionnaire priming methodology was applied to trigger anxiety and consequently activate drinking motives in adult participants ( N = 423). Participants were randomly assigned to the COVID-19 fear priming group or the control group. In the priming group, fear was induced by exposing participants to threatening item stimuli concerning COVID-19 phobias. MANCOVA and ANCOVAs controlling for drinker status were conducted. The COVID-19 fear priming group compared to the control group endorsed significantly higher scores on state assessments of anxiety and coping, conformity, and social drinking motives, but no difference was exhibited on enhancement drinking motives. Furthermore, structural equation modeling showed that state anxiety mediated the causal effects of the COVID-19 fear priming manipulation on each of the four state drinking motives, as supported by tests of indirect effects. After controlling for state anxiety, the fear priming manipulation directly predicted state social drinking motives, but not coping, enhancement, and conformity drinking motives in this model. Additionally, tests of moderated mediation with drinker status as the moderator of the mediational processes were evaluated. The findings indicate that COVID-19 fears in triggering anxiety reactions are subsequently managed through drinking motives in the effort to alleviate the anxiety.
- 2 October 2025
- Published by Taylor & Francis in Journal of Dual Diagnosis
- Vol. 21 (4) , 319-329
Self-Medicating With Alcohol During the COVID-19 Pandemic: COVID-19 Stresses Classify People Into Nondrinkers, Moderate Drinkers, and Binge Drinkers
Objective: People may consume alcohol as a self-medicating strategy to cope with the stressors of the COVID-19 pandemic. The study evaluated COVID-19 stresses in distinguishing nondrinkers, moderate drinkers, and binge drinkers as guided by the self-medication hypothesis. Methods: Adults (N = 484) answered a question assessing drinker type (nondrinkers vs. moderate drinkers vs. binge drinkers) and completed the COVID-19 Stress Scales embodied by the subscales of danger and contamination stress, socioeconomic stress, xenophobia stress, traumatic stress, and compulsive checking stress. Results: Discriminant function analysis using the set of five COVID-19 stress subscales as predictors statistically classified participants into nondrinkers, moderate drinkers, and binge drinkers for the male and female samples. Afterward, 2 (gender: males vs. females) × 3 (drinker status: nondrinkers vs. moderate drinkers vs. binge drinkers) factorial multivariate analysis of variance (MANOVA) and analyses of variance (ANOVAs) scrutinized mean differences. Specifically, males compared to females experienced significantly higher socioeconomic stress, xenophobia stress, traumatic stress, and compulsive checking stress, but no gender difference was exhibited for danger and contamination stress. Furthermore, binge drinkers compared to nondrinkers reported significantly higher scores on all the COVID-19 stress subscales. Binge drinkers compared to moderate drinkers endorsed significantly higher scores on all the COVID-19 stress subscales. Moderate drinkers compared to nondrinkers exhibited significantly higher scores on all COVID-19 subscales except for danger and contamination stress. Conclusions: The findings are consistent with the self-medication, such that people experiencing more COVID-19 pandemic stresses are more likely to consume alcohol in heavier quantities.
- 2 October 2025
- Published by Taylor & Francis in Journal of Dual Diagnosis
- Vol. 21 (4) , 319-329
Self-Medicating With Alcohol During the COVID-19 Pandemic: COVID-19 Stresses Classify People Into Nondrinkers, Moderate Drinkers, and Binge Drinkers
Objective: People may consume alcohol as a self-medicating strategy to cope with the stressors of the COVID-19 pandemic. The study evaluated COVID-19 stresses in distinguishing nondrinkers, moderate drinkers, and binge drinkers as guided by the self-medication hypothesis. Methods: Adults (N = 484) answered a question assessing drinker type (nondrinkers vs. moderate drinkers vs. binge drinkers) and completed the COVID-19 Stress Scales embodied by the subscales of danger and contamination stress, socioeconomic stress, xenophobia stress, traumatic stress, and compulsive checking stress. Results: Discriminant function analysis using the set of five COVID-19 stress subscales as predictors statistically classified participants into nondrinkers, moderate drinkers, and binge drinkers for the male and female samples. Afterward, 2 (gender: males vs. females) × 3 (drinker status: nondrinkers vs. moderate drinkers vs. binge drinkers) factorial multivariate analysis of variance (MANOVA) and analyses of variance (ANOVAs) scrutinized mean differences. Specifically, males compared to females experienced significantly higher socioeconomic stress, xenophobia stress, traumatic stress, and compulsive checking stress, but no gender difference was exhibited for danger and contamination stress. Furthermore, binge drinkers compared to nondrinkers reported significantly higher scores on all the COVID-19 stress subscales. Binge drinkers compared to moderate drinkers endorsed significantly higher scores on all the COVID-19 stress subscales. Moderate drinkers compared to nondrinkers exhibited significantly higher scores on all COVID-19 subscales except for danger and contamination stress. Conclusions: The findings are consistent with the self-medication, such that people experiencing more COVID-19 pandemic stresses are more likely to consume alcohol in heavier quantities.
- 1 October 2025
- Published by Springer Nature
- p. 2019-2031
COVID-19 and Alcohol Use
- 31 August 2025
- Published by Springer Nature
- p. 3273-3287
Cannabis Use Disorders: Measuring Usage
- Open Access
- 10 April 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e66439
Effects of Using a Smart Bassinet on the Mental Health of Military-Affiliated Pregnant Women: Protocol for a Randomized Controlled Sleep Health and Mood in Newly Expectant Military Mothers (SHINE) Trial
Background: Postpartum mood and anxiety disorders (PMADs) are higher among pregnant military service women (26%) and military spouses (12.2%) compared to the civilian population (10%-15%). This is partly due to military-specific factors, including deployment, which are known to increase risk. Important risk factors for PMADs include sleep disturbances, defined as sleep deprivation, insomnia, or poor sleep quality, which are more are common among military-affiliated pregnant women. Objective: This study describes a protocol for a new randomized controlled trial that aims to ameliorate the risk for PMADs through improving infant sleep or maternal sleep during the first 6 postdelivery months in a sample of military-affiliated women. Methods: This study is a 6-month, parallel-arm, randomized controlled trial. Pregnant women (N=342) in the third trimester will be randomized at 1:1 ratio to use a smart bassinet (SB) or a standard commercially available bassinet (HALO BassiNest Swivel Sleeper 3.0; traditional bassinet [TB]) for up to 6 months after delivery. Participants will have their infants sleep in the bassinet, complete monthly web-based questionnaires, and record sleep data with diary and actigraphy for both the participants and their infants for 1 week each postpartum month. Blood samples will also be collected at baseline (late pregnancy) and at 3 months and 6 months post partum to assess immune functioning. The primary outcomes for this study will be postpartum mood (depressive and anxiety symptoms) and infant and maternal sleep. In addition, we are evaluating whether SB has a significant impact on immune functioning—a marker that physiologically connects sleep and mood symptoms. Results: Recruitment for this study began in January 2025. Six separate mixed 2 (treatment vs control) × 6 (assessment period) multivariate analysis of variance and analysis of variance models will be conducted to test the hypotheses that SB will have a greater impact on infant and maternal sleep than TB, SB will be associated with a greater reduction in postpartum mood symptoms than TB, and immune system function will be less dysregulated in birthing individuals using SB compared to those using TB. Lastly, we will evaluate whether the elevated risk demonstrated by previously identified postpartum depression epigenetic biomarkers in the TTC9B and HP1BP3 genes can be modified with an SB. We hypothesize that the elevated risk will be reduced in SB compared to that in TB. Conclusions: At the conclusion of this project, we will have gained a thorough understanding of the capability of SB to positively affect infant and maternal sleep compared to the traditional sleep arrangement and its impact on maternal mood through 6 months post partum in military-affiliated women. The promotion of sleep health in both mothers and infants may be an accessible and amenable method to prevent PMADs. Trial Registration: ClinicalTrials.gov NCT06544941; https://clinicaltrials.gov/study/NCT06544941 International Registered Report Identifier (IRRID): PRR1-10.2196/66439
- 10 April 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e66439
Open AccessEffects of Using a Smart Bassinet on the Mental Health of Military-Affiliated Pregnant Women: Protocol for a Randomized Controlled Sleep Health and Mood in Newly Expectant Military Mothers (SHINE) Trial
Background: Postpartum mood and anxiety disorders (PMADs) are higher among pregnant military service women (26%) and military spouses (12.2%) compared to the civilian population (10%-15%). This is partly due to military-specific factors, including deployment, which are known to increase risk. Important risk factors for PMADs include sleep disturbances, defined as sleep deprivation, insomnia, or poor sleep quality, which are more are common among military-affiliated pregnant women. Objective: This study describes a protocol for a new randomized controlled trial that aims to ameliorate the risk for PMADs through improving infant sleep or maternal sleep during the first 6 postdelivery months in a sample of military-affiliated women. Methods: This study is a 6-month, parallel-arm, randomized controlled trial. Pregnant women (N=342) in the third trimester will be randomized at 1:1 ratio to use a smart bassinet (SB) or a standard commercially available bassinet (HALO BassiNest Swivel Sleeper 3.0; traditional bassinet [TB]) for up to 6 months after delivery. Participants will have their infants sleep in the bassinet, complete monthly web-based questionnaires, and record sleep data with diary and actigraphy for both the participants and their infants for 1 week each postpartum month. Blood samples will also be collected at baseline (late pregnancy) and at 3 months and 6 months post partum to assess immune functioning. The primary outcomes for this study will be postpartum mood (depressive and anxiety symptoms) and infant and maternal sleep. In addition, we are evaluating whether SB has a significant impact on immune functioning—a marker that physiologically connects sleep and mood symptoms. Results: Recruitment for this study began in January 2025. Six separate mixed 2 (treatment vs control) × 6 (assessment period) multivariate analysis of variance and analysis of variance models will be conducted to test the hypotheses that SB will have a greater impact on infant and maternal sleep than TB, SB will be associated with a greater reduction in postpartum mood symptoms than TB, and immune system function will be less dysregulated in birthing individuals using SB compared to those using TB. Lastly, we will evaluate whether the elevated risk demonstrated by previously identified postpartum depression epigenetic biomarkers in the TTC9B and HP1BP3 genes can be modified with an SB. We hypothesize that the elevated risk will be reduced in SB compared to that in TB. Conclusions: At the conclusion of this project, we will have gained a thorough understanding of the capability of SB to positively affect infant and maternal sleep compared to the traditional sleep arrangement and its impact on maternal mood through 6 months post partum in military-affiliated women. The promotion of sleep health in both mothers and infants may be an accessible and amenable method to prevent PMADs. Trial Registration: ClinicalTrials.gov NCT06544941; https://clinicaltrials.gov/study/NCT06544941 International Registered Report Identifier (IRRID): PRR1-10.2196/66439
- 4 October 2024
- Published by Springer Nature
- p. 1-13
COVID-19 and Alcohol Use